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Summary
Insulin-like growth factor-1 (IGF) helps maintain healthy articular cartilage; however, arthritic cartilage becomes less responsive to the anabolic
actions of IGF. We previously showed that high concentrations of nitric oxide (NO) decrease IGF receptor tyrosine phosphorylation and
response to IGF in intact chondrocytes. The current studies evaluate direct effects of NO on IGF receptor kinase (IGF-RK) in vitro. NO from S-
nitroso-N-acetyl-D,L-penicillamine (SNAP) or 1-hydroxy-2-oxo-3-(N-3-methyl-aminopropyl)-3-methyl-1-triazene (NOC-7) inhibits IGF-RK auto-
and substrate phosphorylation in a dose and time dependent manner. There is a linear correlation between inhibition of auto- and substrate
phosphorylation (r2Z 0.98). Increasing either dithiothreitol or reduced glutathione (GSH) content of the phosphorylation buffer to protect thiol
groups blocks NO inhibition of IGF-RK substrate phosphorylation. Increased S-nitrosylation of cysteines in IGF-RK after exposure to SNAP
suggests that NO may react with sulfhydryl groups, form S-nitrosothiols, which may result in functional modiﬁcations. NO blockade of IGF-1
stimulated proteoglycan synthesis in intact cells is enhanced when chondrocyte glutathione is depleted. The in vitro system shows that there
can be direct effects of NO on IGF-RK that modify receptor function; the intact cell studies suggest that the mechanisms identiﬁed in vitro may
be important in intact chondrocyte insensitivity to IGF-1 in cells exposed to NO.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Nitric oxide (NO) is implicated in the disruption or activation
of many chondrocyte functions and may contribute to the
development and progression of arthritis. NO modulates
PGE2 synthesis, blunts chondrocyte integrin signaling, and
under some conditions, may initiate chondrocyte apoptosis.
Some studies show that NO increases active matrix
metalloproteases and inhibits matrix protein synthesis1.
NO is produced by arthritic human cartilage chondrocytes2
and iNOS inhibitors have been used in vivo to blunt
the development of osteoarthritis (OA) induced by joint
instability in canines3.
Insulin-like growth factor-1 (IGF-1), in contrast, is ex-
pressed and produced by chondrocytes and is one of the
anabolic growth factors sustaining cartilage. It is critical for
normal development and growth of cartilage, maintains the
chondrocyte phenotype, is mitogenic (moderately in adult
tissue), is anti-apoptotic, and supports chondrocyte viability.
There is some evidence that IGF-1 can inhibit proteases or
protease activators, and it clearly stimulates collagen and
proteoglycan synthesis in cartilage4. The ﬁrst step in IGF-1
activation of chondrocytes is interaction with the type 1
IGF-1 receptor, which causes auto-phosphorylation of the86receptor intracellular b-subunit, triggering phosphorylation
of downstream signal molecules, and initiating an array of
anabolic effects5.
However, arthritic cartilage is relatively insensitive to the
anabolic actions of IGF-1. This has been attributed to
changes in the IGF-1 binding proteins that modulate the
growth factorereceptor interactions6. An additional factor
may be the presence of NO in arthritic cartilage, for van den
Berg’s group showed that iNOS knockout mice with
zymosan induced arthritis retain sensitivity to IGF-17. On
the basis of this evidence, we initiated studies of the effects
of NO on chondrocyte response to IGF-1. We found that NO
inhibits IGF-1 stimulated proteoglycan synthesis, whether
the NO is from the donor S-nitroso-N-acetyl-D,L-penicilla-
mine (SNAP), DetaNONOate, iNOS, or induced by IL-1.
The effects are dose dependent and reversible. The
physiological relevance of these observations is supported
by data showing that osteoarthritic (OA) cartilage response
to IGF-1 is restored by L-NMA inhibition of NO synthesis.
We also showed that high concentrations of NO decrease
IGF-1 receptor auto-phosphorylation, the ﬁrst step in IGF-1/
cell signaling8.
The mechanisms involved in NO actions differ depending
on exposure time and concentration, with lower concen-
trations effecting changes in cell function via activation of
guanylate cyclase, and increases in cGMP9. We found that
inhibiting cGMP dependent protein kinase can enhance
arthritic cartilage anabolic responses to IGF-1, suggesting
that NO inhibition of IGF-1 stimulated cartilage proteoglycan
synthesis is effected, at least in part, via this pathway10.
Deﬁning the mechanisms by which higher concentrations
of NO might modify IGF-1 receptor phosphorylation, and
thus subsequent cell activation, is confounded by the3
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Drawing on data from other cell systems, NO (rather the
reactive nitrogen oxide species derived from reaction of
oxygen with NO11,12) could directly modify the receptor
kinase by S-nitrosylation. NO could react with superoxide, if
present, to form peroxynitrite, which could alter the receptor
by tyrosine nitration of the IGF-1 receptor13. NO under
some conditions can decrease chondrocyte ATP stores14,
or in other cells, activate phospho-tyrosine phosphatases15
that could contribute to the observed decrease in IGF-1
receptor auto-phosphorylation. To exclude these confound-
ing factors, the current studies use two different prepara-
tions of recombinant IGF-1 receptor kinase (IGF-RK) to
deﬁne speciﬁc effects of NO on IGF-1 receptor auto- and
substrate phosphorylation. NO can effect S-nitrosylation of
IGF-RK and depleting chondrocyte thiol-protective glutathi-
one enhances NO inhibition of IGF actions in intact
chondrocytes. The data suggest that mechanisms identiﬁed
for NO modulation of IGF-1 signaling in the cell free system
may be applicable to the actions of NO in chondrocytes and
thus of importance in the pathophysiology of cartilage.
Materials and methods
MATERIALS
Human recombinant IGF-RK was obtained from Biomol
(#SE-232, Plymouth Meeting, PA) as a GST fusion protein
containing the Mr 46 kDa cytoplasmic domain of the
b-subunit, residues 930e1337. This intracellular subunit
includes binding sites for IRS-1, Shc, and ATP, the tyrosine
kinase cluster at Y1131e36, and the C-terminal section
containing several function speciﬁc binding sites. It can be
used as a dimer, or after cleavage into monomers by
incubating with thrombin at 0.1e0.2 U/100 mg protein16.
These studies were done with the dimer, and a second
preparation (USB, Lake Placid, NY; #14-465) containing
residues 959-end with an N-terminal His6-tag was used to
verify results obtained with the Biomol preparation. SNAP,
1-hydroxy-2-oxo-3-(N-3-methyl-aminopropyl)-3-methyl-1-tri-
azene (NOC-7) and 5-nitrosoglutathione (GSNO) were from
Alexis (San Diego, CA). New Zealand white rabbits, 5e6 lb,
were from Myrtle’s Rabbitry (Thompson Station, TN);
buthionine sulfoximine (BSO), Eagle’s minimum essential
medium (MEM), fetal calf serum (FCS), antibiotics, and
other tissue culture supplies were from SigmaeAldrich (St
Louis, MO); Type 1 collagenase and trypsin were from
Worthington Biochemical (Freehold, NJ); 35S-sodium sul-
fate, 1 Ci/mmol, was from NEN (Boston, MA); human IGF-I
was from R&D Systems (Minneapolis, MN). The glutathione
assay kit was from Cayman (Ann Arbor, MI). All other
reagents were obtained from SigmaeAldrich (St Louis, MO).
RECEPTOR TREATMENT
For studies involving receptor function (substrate phos-
phorylation), IGF-RK (2.5 mg/ml) was incubated with NO
donor or vehicle in a phosphorylation buffer (PB)16,17
containing 50 mM Tris, pH 7.5, 5 mM MgCl2, 5 mM
MnCl24H2O, 0.03% ovalbumin, and variable concentra-
tions of dithiothreitol (DTT) or reduced glutathione (GSH).
Incubation/exposure of IGF-RK to NO generated by donors
for variable times at room temperature was done in a total
volume of 150 ml/reaction tube (RX). For auto-phosphory-
lation and S-nitrosylation studies, 0.25e0.5 mg IGF-RK wasincubated under similar conditions, but in 10e12 ml total
volumes.
AUTO-PHOSPHORYLATION
A cocktail to give a ﬁnal concentration of 100 mM ATP and
5 mCi [g-32P] ATP/reaction tube was added to the IGF-RK
after NO exposure. Incubation was continued for 15 min at
room temperature; 12 ml 2! Laemelli buffer containing
100 mM PMSF and 4% beta-mercaptoethanol was added,
the samples were heated to 95(C for 5 min, and the proteins
separated on 4e15% gels (Biorad, Hercules, CA). The gels
were ﬁxed in 30% ethanol/10% acetic acid overnight with
two changes of ﬁxative, washed 1! with water, and dried.
The phosphorylated proteins were localized by autoradiog-
raphy and relative density of the bands was evaluated using
a BioRad GS-800 Densitometer.
SUBSTRATE PHOSPHORYLATION
Contents of the RX tubes were removed in 20 ml aliquots
(0.05 mg IGF-RK) to micro tubes containing 5 ml PB (sub-
strate-free ‘control’) or 25 mg poly(glu, tyr) 4:1, a non-
speciﬁc tyrosine kinase substrate (Sigma P-0275). The
substrate phosphorylation reaction was allowed to proceed
for 15 min at room temperature. Aliquots (20 ml) of the
reaction mixtures were spotted to circles of P-81 phospho-
cellulose paper, immersed in cold 10% TCA, 10 mM
pyrophosphate, and washed 3! for 20 min each time.
The papers were dried, and the radioactivity incorporated
into substrate determined by scintillation counting. The data
were corrected for background radioactivity and the counts
from receptor phosphorylation in substrate-free ‘control’
tubes (usually less than 10% of the total counts), and
expressed as pmol 32P incorporated/15 min or as % control
IGF-RK not exposed to NO.
S-NITROSYLATION
S-nitrosylation was determined using the ‘biotin switch’
method described by Jaffrey et al.18,19 using the NitroGlo
Nitrosylation Detection Kit (PerkineElmer). Following in-
cubation with NO donors, free thiols were blocked with
methyl methanethiosulfonate (MMTS) in the presence of
SDS to ensure access to buried cysteines. Acetone
precipitation and washing was done to remove MMTS,
nitrosothiol bonds were decomposed with ascorbate, and
thiols were reacted with N-[6-(biotinamido)hexyl]-3#-(2#-
pyridyldithio) propionamide (biotineHPDP). The preparation
was then subjected to SDS-gel electrophoresis, the proteins
were transferred to nitrocellulose membrane, and the
biotinylated proteins detected with anti-biotin mouse mono-
clonal antibody, sheep anti-mouseeHRP conjugate, and
ECL (Amersham Pharmacia Biotech).
CHONDROCYTE STUDIES
Rabbits were euthanized using a protocol approved by the
IACUC of the Pittsburgh, PA VA Healthcare System.
Chondrocytes were isolated from knee and shoulder joints
ofmatureNewZealandwhite rabbits and the cells cultured as
previously described8. Cells were grown to 80% conﬂuence
in Falcon Multiwell, 24 well plates, and medium serum was
reduced to 1%24 h before addition of BSO; 7 h later SNAPor
DMSO vehicle at!0.5% was added. IGF-1 (100 ng/ml) was
865Osteoarthritis and Cartilage Vol. 12, No. 11added 1 h after SNAP and proteoglycan synthesis and
glutathione content were determined 24 h later.
Proteoglycan synthesis was measured as the incorpora-
tion of 35S-sulfate (6 h pulse label) into molecules separated
from unincorporated label using PD-10 columns as de-
scribed for this lab8. Chondrocyte glutathione was assayed
in lysates of cells incubated under the same conditions as
for proteoglycan synthesis using the enzymatic recycling of
glutathione reductase with the Cayman kit as directed.
STATISTICS
Experiments were repeated at least three times and data
are presented as meansG SE. Analysis of variance was
used to compare groups and the signiﬁcance of differences
between mean values was determined by t-test.
Results
Figure 1 shows the concentration and time dependent
inhibition of (Biomol) IGF-RK substrate phosphorylation by
the NO donor SNAP. The concentration of SNAP varied
from 0.2 to 2 mM and the receptor exposure time was 3 h.
Under these conditions, IGF-RK substrate phosphorylation
is signiﬁcantly inhibited at all concentrations of SNAP
(P! 0.05 when comparing the data from IGF-RK exposed
to DMSO vehicle to that of the receptor exposed to 0.2, 1,
and 2 mM SNAP). The bottom panel shows the time
dependent effect of NO on IGF-RK substrate phosphoryla-
tion. IGF-RK was exposed to 1 mM SNAP for 1e5 h and
substrate phosphorylation was determined. IGF-RK sub-
strate phosphorylation was decreased to 82G 4% (1 h),
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Fig. 1. NO inhibition of IGF-RK substrate phosphorylation is con-
centration (top panel) and time dependent (bottom panel). IGF-RK
(Biomol) was incubated with 0.2e2 mM SNAP or DMSO vehicle for
3 h, 100 mM 32P-ATP added for 15 min, and phosphorylation of the
substrate poly(glu, tyr) 4:1 determined as described in Materials
and Methods. SNAP (1 mM) was used to assess the time
dependent effect of NO on IGF-RK substrate phosphorylation.
Values are meanG SE of nZ 12 (top) or 6e9 (bottom), and all are
signiﬁcantly less than vehicle treated control at P! 0.05.71G 3% (3 h), and 54G 7% (5 h), and all values are
signiﬁcantly less than control.
Figure 2 (top) is a representative autoradiograph of IGF-
RK auto-phosphorylation. The upper 72 kDa bands show
auto-phosphorylation of IGF-RK; the lower band at 47 kDa
is the non-speciﬁc phosphorylation of the carrier protein
ovalbumin, which can be used as a reference for sample
loading. The conditions for this speciﬁc experiment were
2 mM DTT with 3 h exposure to SNAP. Auto-phosphoryla-
tion of IGF-RK exposed to NO was 59%, 50%, and 25% of
the DMSO control. The bottom panel shows substrate
phosphorylation as a function of auto-phosphorylation
assayed from separate experiments but under identical
conditions of IGF-RK exposure to NO. There is a linear
relation between auto- and substrate phosphorylation, with
a correlation coefﬁcient of 0.9832.
An important consideration when using NO donors is the
pattern of NO release. A donor like SNAP, with a half-life
between 5 and 7 h under the incubation conditions of these
experiments, will deliver NO with concentrations rising to
a relatively steady state, and then decreasing slowly. Thus
high concentrations of NO will be present during the
‘exposure’, ‘auto-phosphorylation’, and ‘substrate phos-
phorylation’ phases of the experiment, and NO could affect
the substrate phosphorylation reaction directly. To preclude
this possibility, we also conducted studies with NOC-7, an
NO donor with a half-life of 10 min. In these experiments,
NO concentrations increase rapidly, decline rapidly, and
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Fig. 2. Representative autoradiogram of IGF-RK auto-phosphory-
lation (top) and correlation between auto-phosphorylation and
substrate phosphorylation (bottom) by IGF-RK exposed to NO
from the donor SNAP. IGF-RK was exposed to variable concen-
trations of SNAP for 2 h before addition of 100 mM 32P-ATP. Fifteen
minutes later the reaction was quenched by addition of 2!
Laemelli buffer and auto-phosphorylation assessed as described
in Materials and Methods. The data for the bottom panel are
meanG SE of nZ 2e3 values for auto-phosphorylation and
nZ 12 values for substrate phosphorylation. SNAP concentrations
ranged from 0.1 to 2 mM and SNAP exposure times ranged from 1
to 3 h. Regression analysis by the least squares method was used
to deﬁne the slope and intercept of the line describing the
relationship between auto- and substrate phosphorylation. The
adjusted r2 value of 0.98 indicates a signiﬁcant linear relationship
between these parameters.
866 R. K. Studer: Nitric Oxide and IGF-1 receptor functionlimit the time of IGF-RK exposure to NO. NOC-7 NO release
is negligible after 80 min (i.e. eight half-lives, 0.325%
remaining) providing minimal concentrations of NO during
the substrate phosphorylation reaction, and obviating any
potential NO effects on this reaction per se. IGF-RK
substrate phosphorylation following exposure to NO re-
leased by 0.25e1 mM NOC-7 is shown in Fig. 3. All values
are signiﬁcantly less than control with substrate phosphor-
ylation diminished to 72G 4%, 63G 2%, and 60G 2% of
control after 2 h incubation with 0.25 mM, 0.5 mM, or 1 mM
NOC-7, respectively.
GSNO is another carrier of NO that can modulate protein
function by transnitrosylation as well as NO release. As
seen in Fig. 3, IGF-1RK exposed to GSNO showed a dose
dependent decrease in substrate phosphorylation. These
data are suggestive of receptor S-nitrosylation being
involved in NO modulation of receptor function.
The preceding studies were done with the Biomol IGF-1
receptoreGST fusion protein; thus it is possible that the
effects of NO are secondary to interaction with the GST
fusion protein in a way that would modify dimerization and
thus auto- and substrate phosphorylation. As the Biomol
IGF-RK preparation was used as a dimer, NO would have
to cause dissociation to the monomer to give the observed
effects; given the characteristics of the preparation, this was
considered unlikely16,17. However, to exclude this possibil-
ity, identical experiments were done using the IGF-RK His6
tagged preparation from USB. The decreases in IGF-RK
substrate phosphorylation by both preparations in the
presence of two separate NO donors were similar:
exposure to 1 mM SNAP for 3 h inhibited phosphorylation
by the Biomol preparation to 67G 2% of control (nZ 12)
while inhibiting the USB preparation substrate phosphory-
lation to 68G 5% of control (nZ 6). Exposure to 1 mM
NOC-7 for 2 h decreased Biomol IGF-RK substrate
phosphorylation to 67G 2% of control (nZ 12) while
decreasing USB IGF-RK substrate phosphorylation to
60G 4% of control (nZ 12). The data suggest that the
effect of NO on IGF-RK substrate phosphorylation is
independent of the fusion protein, and thus most likely
due to interactions with the receptor itself.
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Fig. 3. IGF-RK substrate phosphorylation is inhibited by exposure
to the short half-life NO donor NOC-7 and the S-nitrosylating donor
GSNO. IGF-RK was incubated with variable concentrations of
NOC-7 (t1/2Z 10 min) for 2 h or with GSNO for 3 h before substrate
phosphorylation was measured as described in Materials and
Methods. Values are meanG SE of nZ 6 (NOC-7) or nZ 9
(GSNO). All values are signiﬁcantly less than the appropriate
vehicle control at P! 0.05 (NOC-7 vehicleZ 5 mM NaOH: GSNO
vehicleZ water).To evaluate whether S-nitrosylation of IGF-RK might be
involved in NO inhibition of auto-, and thus subsequent
substrate phosphorylation, we varied the concentration of
the thiol-protective, reducing agent dithiothreitol in the
reaction buffer. The results of experiments using SNAP
(DTT at 2 and 5 mM) and NOC-7 (DTT from 2 to 10 mM) are
shown in Fig. 4. Increasing DTT to 5 mM blunts the effect of
NO, while increasing it to 10 mM blocks the ability of NO
from either SNAP or NOC-7 to inhibit IGF-RK substrate
phosphorylation completely.
A separate series of experiments tested whether reduced
glutathione (GSH) could blunt the effect of NOC-7 on
substrate phosphorylation by the USB IGF-RK preparation.
The reaction buffer contained 2 mM DTT with either 0,
1 mM, or 2 mM added GSH. NOC-7 inhibited substrate
phosphorylation to 65G 8% of control in the absence of
GSH. This effect was reduced to 75G 6% of control with
1 mM GSH, and prevented completely (103G 2% of
control) by addition of 2 mM GSH. These studies also
suggest S-nitrosylation as a mechanism by which NO may
blunt IGF-RK substrate phosphorylation.
Figure 5 is a representative Western blot of IGF-RK
following exposure to SNAP and processing for detection of
S-nitrosylated cysteines by the ‘biotin switch’ method18,19
as described in Materials and Methods. S-nitrosylation of
the IGF-1 receptor by NO under these incubation conditions
is clearly demonstrated.
The blockade of NO effects on IGF-RK substrate
phosphorylation by DTT and GSH suggests that chondro-
cyte thiol status could modulate the actions of NO on IGF-1
receptor function in vivo. Data from experiments with
chondrocytes in monolayer culture treated for 24 h with
BSO, a speciﬁc inhibitor of g-glutamylcysteine synthetase
that will deplete intracellular glutathione20, are shown in
Fig. 6. BSO at 0.1 mM modestly decreased IGF-I stimula-
tion of proteoglycan synthesis. SNAP alone inhibited IGF-1
stimulated proteoglycan synthesis under these incu-
bation conditions, and this effect was enhanced in
glutathione depleted chondrocytes. Total glutathione con-
centrations were (nmol/mg protein): controlZ 8.0G 2;
IGFZ 10.9G 2.8; 0.1 mM BSOZ 1.14G 0.3. Exposure
to SNAP under these same conditions did not modify
cell glutathione: 0.1 mM SNAPZ 10.6G 2; SNAP -
C IGFZ 9.1G 1.6; SNAPC BSOZ 1.42G 0.7 (mean -
G SE of nZ 3e5). Parallel studies of chondrocyte
viability using MTT showed no decrease in the number of
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Fig. 4. Increasing DTT blocks NO inhibition of IGF-RK substrate
phosphorylation. IGF-RK was incubated with 1 mM NOC-7 for 2 h
or SNAP for 3 h with DTT from 2.0 to 10 mM and substrate
phosphorylation determined as described in Materials and Meth-
ods. Values are meanG SE of nZ 8e16. *P! 0.05 vs 2 mM DTT.
867Osteoarthritis and Cartilage Vol. 12, No. 11live cells within 24 h of treatment with BSO and SNAP;
chondrocytes cultured in low serum and 0.5 mM BSO for
72 h did show signiﬁcant loss of viability (data not shown).
Discussion
The in vitro studies conﬁrm that NO can diminish IGF-RK
auto-phosphorylation as suggested by our initial studies
with intact chondrocytes8. Phosphatases were not present
in the in vitro system; thus we can conclude that NO is
capable of decreasing IGF-RK auto-phosphorylation per se,
and the decreased receptor phosphorylation is not second-
ary to NO effects on protein tyrosine phosphatases.
However, the data do not exclude a contribution in intact
chondrocytes from NO/phosphatase regulation as has been
observed in other cell types15.
The data do not exclude actions via peroxynitrite
modiﬁcation of receptor phosphorylation/function under
in vivo conditions where both NO and superoxide may be
present, as may occur in rheumatoid arthritis and even in
some phases of OA21. Co-localization of IL-1 (which
induces iNOS) with nitrotyrosine in human OA cartilage
suggests that such a mechanism may in fact contribute to
Fig. 5. S-nitrosylation of IGF-RK exposed to NO from SNAP. IGF-
RK (USB) was incubated with DMSO (Lane 1), 1 mM SNAP (Lane
2) or 2 mM SNAP (Lane 3) for 3 h in PB containing 1 mM DTT.
S-nitrosylation was determined as described in Materials
and Methods. Results are representative of three separate
experiments.
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Fig. 6. NO inhibition of IGF-1 stimulated proteoglycan synthesis is
enhanced by chondrocyte glutathione depletion. Rabbit chondro-
cytes were grown to conﬂuence and medium serum concentration
reduced to 0.5% for 24 h before addition of BSO at 0.1 mM
(tZ 0 h). Seven hours later 0.1 mM SNAP or DMSO vehicle was
added as noted, and some cells were exposed to 100 ng/ml IGF-1
at tZ 8 h. Proteoglycan synthesis was determined from a 6 h pulse
labeling with 35S-sulfate 24 h later. Values are meanG SE of
nZ 3e8. *P! 0.05 vs vehicle; #P! 0.05 vs IGF-1.NO blunting of IGF-1 actions in vivo22. These studies by
Loeser et al. showed that cartilage with increased
nitrotyrosine was also resistant to the anabolic actions of
IGF-122. Furthermore, we have done preliminary studies
exposing IGF-RK to SIN-1, which generates both NO and
superoxide, and thus, potentially, peroxynitrite. Substrate
phosphorylation was reduced to 53G 2% of control after
2 h exposure to 1 mM SIN-1 and to 37G 3% of control after
3 h exposure (nZ 9 in both cases). These in vitro experi-
ments suggest that multiple mechanisms for NO modulation
of IGF-RK function may exist in the complex environment of
the intact chondrocyte.
While not excluding alternative in vivo mechanisms, the
current studies clearly show direct NO dependent modula-
tion of IGF-RK auto-phosphorylation and function as
assessed by substrate phosphorylation. Furthermore, the
blockade of the NO effect by high concentrations of the
thiol-protective agents DTT and GSH suggests that
S-nitrosylation of critical thiol containing residues of the
receptor can effect this change. The IGF-RK S-nitrosylation
signal detected following exposure to 1 mM SNAP is
relatively weak; this may be in part due to the complexities
of the ‘biotin switch’ methodology with its blocking and
subsequent tagging of the modiﬁed thiol groups. However,
the data clearly demonstrate that under these in vitro, cell
free conditions, reactive NO species can affect cysteine
nitrosylation of IGF-RK, which we presume contributes to
the decrease in substrate phosphorylation. Whether similar
effects can be demonstrated in the intact chondrocyte
remains to be evaluated. The concentrations of NO
generated by SNAP and/or NOC-7 in these current experi-
ments are higher than those produced by cytokine activated
chondrocytes8. However, reactions in vivo will be dictated
by the context of the in situ receptor environment that will
impact the reactivity of thiols to NO species11,12.
Nitrosylation is increasingly seen as an important
modulator of protein function. Activation and inhibition of
diverse activities including protein kinases/phosphatases,
metabolic enzymes, signaling proteins, proteases, respira-
tory proteins and transcription factors have been docu-
mented [recently reviewed by Stamler et al.23]. Two
previous reports are pertinent to our observations of effects
of NO on IGF-1 signaling. Estrada et al.24 reported
reversible, DTT modulable NO inhibition of EGF receptor
auto-phosphorylation in transfected ﬁbroblasts overex-
pressing the human epidermal growth factor receptor.
Schmid et al.25 showed that CHO-hIR cells exposed to
DEA-NO or SNAP had diminished insulin beta-receptor
auto-phosphorylation. Modeling of the insulin receptor beta
chain showed that nitrosylation of any one of the four
cysteine residues in the insulin receptor kinase (I-RK) leads
to changes in the crystalline structure of the receptor which
have been hypothesized to diminish expression of catalytic
activity. There is approximately 90% homology of the insulin
and IGF-1 receptor intracellular domains and complete
identity in cysteines 1056, 1138, 1234, and 1245 in the
kinase domain26. Thus the DTT sensitive modulation of
auto- and substrate phosphorylation and enhanced
S-nitrosylation of the IGF-1 receptor we observed in our
experiments is consistent with these earlier studies of the
insulin receptor. Further evaluation of the IGF-1 receptor,
both in vitro and in intact cells, is necessary to establish
structural/functional modiﬁcations subsequent to exposure
to NO and/or its reactive byproducts.
Glutathione depletion under some conditions can reduce
chondrocyte biosynthesis of both proteoglycan and colla-
gen20; however, under the conditions of the current studies,
868 R. K. Studer: Nitric Oxide and IGF-1 receptor functionit did not diminish basal proteoglycan synthesis (Fig. 6).
Rather, it did signiﬁcantly inhibit IGF-1 stimulated synthesis,
and enhanced the effect of NO to decrease basal and IGF-1
stimulated matrix protein synthesis. Previous studies have
shown that GSH depletion decreases bovine and chick
chondrocyte viability when the cells are challenged with
hydrogen peroxide plus NO27,28, and increases human
chondrocyte apoptosis in cells challenged with peroxyni-
trite29. The current work complements these earlier studies
as it shows modulation of growth factor stimulation of
proteoglycan synthesis, and enhancement of NO actions to
blunt IGF-1 actions. These more subtle effects were seen at
NO concentrations that do not cause loss of cell viabili-
ty29,30. Whether these actions are the result of NO
S-nitrosylation of IGF-1 receptor and subsequent diminution
of function, as can be seen in in vitro experiments, or also
involve other complex reactions related to the inability of
glutathione depleted cells to withstand nitrosative and/or
oxidative stress remains an intriguing question for future
experiments.
In conclusion, these studies show that NO dose and time
dependently inhibits auto- and substrate phosphorylation of
the IGF-1 receptor in an in vitro incubation system. The
results are similar with SNAP (t1/2 of 5 h) and NOC-7 (t1/2 of
10 min), and with two different receptor preparations,
suggesting that NO effects on IGF-RK per se are re-
sponsible for these observations. The thiol-protective
agents DTT and GSH block NO inhibition of IGF-RK
substrate phosphorylation, and nitrosylation of IGF-RK
cysteines is detected following exposure to NO. This
suggests that NO dependent S-nitrosylation can modulate
receptor function. Depleting chondrocytes of glutathione
and thus minimizing their thiol-reductive reserve enhances
the action of NO to blunt the response of these cells to the
anabolic action of IGF-1. Deﬁnition of the speciﬁc mecha-
nisms involved in the modulation of NO effects in
glutathione depleted cells will require extensive analysis
of intact chondrocyte preparations. Regardless, the in vitro
system is useful for deﬁning effects of NO on growth factor
receptor structure and function. The data thus derived can
be used to more effectively design studies to discern the
mechanisms actually involved in NO modulation of IGF-I
receptor signaling in the intact chondrocyte, and eventually
in chondrocytes in situ in the cartilage matrix.
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